An evidence-based review of therapies for canine chronic kidney disease.
Successful treatment and prevention of kidney disease in dogs requires a multi-dimensional approach to identify and eliminate causes or exacerbating factors, provide professional evaluation on a regular basis and implement a comprehensive treatment programme when necessary. Over the years, many therapeutic and preventive interventions have been developed or advocated for chronic kidney disease in dogs, but evidence of efficacy or effectiveness is often lacking or highly variable. Accordingly, the main objective of this systematic review was to identify and critically appraise the evidence supporting various aspects of managing canine chronic kidney disease.
Roudebush
P
P
Scientific Affairs, Hill's Pet Nutrition, Inc., Topeka, KS 66601, USA.
Polzin
D J
DJ
Adams
L G
LG
Towell
T L
TL
Forrester
S D
SD
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000821:Animal Feed; D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use; D000975:Antioxidants / Q000627:therapeutic use; D002117:Calcitriol / Q000627:therapeutic use; D004283:Dog Diseases / Q000178:diet therapy / Q000628:therapy*; D004285:Dogs; D004921:Erythropoietin / Q000627:therapeutic use; D055317:Evidence-Based Practice; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use; D005440:Fluid Therapy / Q000662:veterinary; D007676:Kidney Failure, Chronic / Q000628:therapy / Q000662:veterinary*
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D000975:Antioxidants; D015525:Fatty Acids, Omega-3; D004921:Erythropoietin; D002117:Calcitriol